These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5182290)

  • 21. [Therapy with PAS, rifamycin and ethionamide administered intravenously and its effects on glucide metabolism in diabetics affected by pulmonary tuberculosis].
    Filla E; Comenale D
    Minerva Med; 1965 Dec; 56(103):4570-3. PubMed ID: 5858896
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug intolerance and depressive states in tubercular patients].
    Scherding JP; Suerinck E
    Rev Tuberc Pneumol (Paris); 1967; 31(1):55-60. PubMed ID: 6037247
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative clinical study of prothionamide and ethionamide in the treatment of pulmonary tuberculosis].
    Shmelev NA; Korotaev GA; Poleshchuk AK; Utkin VV; Golitsyna LV
    Probl Tuberk; 1969; 47(1):27-33. PubMed ID: 5380204
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypersensitivity reactions to antituberculous drugs in pulmonary tuberculosis].
    Dukalski J; Stański K
    Gruzlica; 1969 Oct; 37(10):937-41. PubMed ID: 5366986
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of patients with pulmonary tuberculosis, complicated by peptic ulcer, with ethionamide and prothionamide].
    Samtsov VS
    Probl Tuberk; 1973; 51(7):67-70. PubMed ID: 4767522
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disturbances in the thyroid function during the treatment with the para-aminosalicylic acid derivatives.
    Górowski T; Gasiorowski W
    Pol Med J; 1968; 7(3):638-42. PubMed ID: 5669704
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neuropsychiatric incidences in antitubercular treatment consisting of isoniazid or isoniazid and ethionamide (8 cases)].
    Bleandonu G; Boye J
    Ann Med Psychol (Paris); 1969 Jul; 127(2):201-26. PubMed ID: 4254305
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of isoniazid and PAS on various biochemical indices of liver function in patients with tuberculosis].
    Savula MM; Tytor IaN
    Vrach Delo; 1983 Jul; (7):16-9. PubMed ID: 6624048
    [No Abstract]   [Full Text] [Related]  

  • 31. [Aluminum and magnesium pentasilicates associated with pectin and sorbitol in gastrointestinal disorders observed in children during treatment by tuberculostatics].
    Gerbeaux J; Baculard A; Hanoteau J
    Actual Hepatogastroenterol (Paris); 1968; 4(1):B23-4. PubMed ID: 5721702
    [No Abstract]   [Full Text] [Related]  

  • 32. [Para-aminosalicylic acid metabolism in the body. VII. Resorption and tolerance of calcium-PAS compound and early results of treatment of pulmonary tuberculosis].
    Owsiński J; Kamińska M; Ostrowska A; Rapf T
    Gruzlica; 1972 Jul; 40(7):635-7. PubMed ID: 5053842
    [No Abstract]   [Full Text] [Related]  

  • 33. [On a case of simple goiter in a tuberculous subject treated with para-aminosalicylic acid].
    De Sanctis G; Petreni R
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1433-8. PubMed ID: 5760383
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tolerance of ethionamide in patients with tuberculosis complicated by peptic ulcer and chronic gastritis].
    Petrenko VM
    Vrach Delo; 1977 Aug; (8):61-5. PubMed ID: 919450
    [No Abstract]   [Full Text] [Related]  

  • 35. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum transaminase levels in pulmonary tuberculosis. Effect of triple treatment with 4-4 1-di-isoamyloxythiocarbanilide or PAS in combination with streptomycin and isoniazid.
    Ockerman PA; Ryde C
    Scand J Respir Dis; 1968; 49(1):35-41. PubMed ID: 5187250
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of prothionamide in the treatment of pulmonary tuberculosis].
    Voitova DI; Zaitseva TI; Leont'eva GP; Milinder NM; Charikova LP
    Probl Tuberk; 1971; 49(7):24-7. PubMed ID: 5162994
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cases of leukopenia caused by PAS allergy].
    Fukui S
    Iryo; 1966 Mar; 20(3):282-5. PubMed ID: 5964835
    [No Abstract]   [Full Text] [Related]  

  • 40. [Side effects of ETA combined with INH and SM in the first antituberculous treatment of pulmonary tuberculosis].
    Sosnowski W; Rozniecki J; Kubiak Z; Pruszyńska S
    Gruzlica; 1968 Oct; 36(10):983-5. PubMed ID: 5710105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.